Biopotential, Osta Announce Signing of Share Exchange Agreement

Biopotential Capital, a capital pool company listed on the TSX Venture Exchange, announced that it has signed the share exchange agreement with Osta Biopharma, a Montreal-based private company specializing in developing novel diagnostics and therapeutics for osteoporosis and osteoarthritis. The arm's length agreement provides for the acquisition by Biopotential of all the issued and outstanding shares of Osta for an aggregate purchase price of approximately $7.45 million, payable by the issuance of 21,289,504 Biopotential common shares at a price of $0.35 per share.

CCNMatthews (http://www2.ccnmatthews.com/scripts/ccn-release.pl?/2005/02/14/0214127n.html)